La Crosse, WI, United States of America

Dean A Jobe

This inventor holds 2 USPTO granted patents. Top assignee: Gundersen Lutheran Medical Foundation, Inc.. Active years: 2001-2002.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2001-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Dean A Jobe in Lyme Disease Diagnosis and Prevention

Introduction

Dean A Jobe is an accomplished inventor based in La Crosse, WI (US). He has made significant contributions to the field of medical research, particularly in the diagnosis and prevention of Lyme disease. With a total of 2 patents to his name, his work focuses on innovative methods that can potentially save lives.

Latest Patents

Dean A Jobe's latest patents include compositions and methods using the borreliacidal epitope(s) of Borrelia burgdorferi outer surface protein C (OspC) for the diagnosis and prevention of Lyme disease. One of his notable inventions describes an OspC Dra fragment fusion peptide isolated for the prevention, treatment, and early diagnosis of Lyme disease in humans and other animals. This invention also relates to a screening method for detecting anti-Osp borreliacidal antibody activity, as well as antibodies reacting with a protein fragment encoded by a DraI-SmaI DNA fragment of OspC.

Career Highlights

Dean A Jobe is associated with Gundersen Lutheran Medical Foundation, Inc., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on public health, particularly in combating Lyme disease.

Collaborations

Some of his notable coworkers include Steven M Callister and Steven D Lovrich, who have collaborated with him on various projects related to his patents.

Conclusion

Dean A Jobe's contributions to the field of Lyme disease research highlight the importance of innovation in medical science. His patents reflect a commitment to improving diagnosis and treatment options for this prevalent disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…